Key facts
- This page summarizes Christopher Gibson's Form 4 filing for RECURSION PHARMACEUTICALS, INC. (RXRX).
- 3 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 09 Mar 2022, 19:44.
Christopher Gibson - 07 Mar 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- RXRX
- Reported as of
- 07 Mar 2022
- Net transaction value
- -$2,188,950
- SEC form
- 4
- Accepted by SEC
- 09 Mar 2022, 19:44:15 UTC
- Prior SEC filing
- 24 Feb 2022
- Next SEC filing
- 15 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nathan Hatfield, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher Gibson filed Form 4 for RECURSION PHARMACEUTICALS, INC. (RXRX) on 09 Mar 2022.
Change
- Previous filing in this sequence was filed on 24 Feb 2022.
- Current net transaction value: -$2,188,950.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RXRX
transaction
Class A Common Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- +300,000
- Change %
- +128%
- Price
- $0.000000
- Shares after
- 534,020
- Date
- 07 Mar 2022
- Ownership
- Direct
- Footnotes
- F1, F2
RXRX
transaction
Class A Common Stock
Sale
- Transaction value
- $2,188,950
- Shares
- -300,000
- Change %
- -56%
- Price
- $7.30
- Shares after
- 234,020
- Date
- 07 Mar 2022
- Ownership
- Direct
- Footnotes
- F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RXRX
transaction
Derivative
Class B Common Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -300,000
- Change %
- -3.9%
- Price
- $0.000000
- Shares after
- 7,358,484
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 7,358,484
- Exercise price
- $0.000000
- Footnotes
- F1, F2
RXRX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 416,350
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 416,350
- Exercise price
- $11.40
- Footnotes
- F5
RXRX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,436
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,436
- Exercise price
- $11.40
RXRX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,471,354
- Date
- 07 Mar 2022
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 1,471,354
- Exercise price
- $2.47
- Footnotes
- F6
RXRX
holding
Derivative
Class B Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 550,000
- Date
- 07 Mar 2022
- Ownership
- by LAHWRAN-3 LLC
- Underlying class
- Class A Common Stock
- Underlying amount
- 550,000
- Exercise price
- $0.000000
- Footnotes
- F2, F7
RXRX
holding
Derivative
Class B Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 550,000
- Date
- 07 Mar 2022
- Ownership
- by LAHWRAN-4 LLC
- Underlying class
- Class A Common Stock
- Underlying amount
- 550,000
- Exercise price
- $0.000000
- Footnotes
- F2, F8
RXRX
holding
Derivative
Class B Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 146,875
- Date
- 07 Mar 2022
- Ownership
- by Gibson Family Trust
- Underlying class
- Class A Common Stock
- Underlying amount
- 146,875
- Exercise price
- $0.000000
- Footnotes
- F2, F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
Represents the conversion of Class B Common Stock into Class A Common Stock.
Footnote F2
Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
Footnote F3
Shares were sold by a lender to the Reporting Person to satisfy a margin call related to a loan in which the shares served as collateral.
Footnote F4
This transaction was executed in multiple trades at prices ranging from $7.06 to $7.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Footnote F5
The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
Footnote F6
The option, originally for 1,500,000 shares, of which 28,646 shares have been exercised, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Footnote F7
The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
Footnote F8
The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
Footnote F9
The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.